Dr. Andrew Charles Kline, MD

Dr. Kline practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health.

Dr. Kline's NPI, 1275915217, was assigned on June 26, 2015. Dr. Kline graduated from Michigan State University College of Human Medicine in 2015. Dr. Kline holds Michigan license 4301108250.

Dr. Kline's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth, at 100 Michigan St NE, Grand Rapids, MI 49503 in Kent County. The practice phone is (616) 391-1774.

Dr. Kline's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health. Dr. Kline is also affiliated with Corewell Health Zeeland Hospital. The medical group on file is Emergency Care Specialists (ECS). Dmand AI also links Dr. Kline to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kline practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Kline's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Kline is licensed in Michigan.

CMS data shows 91 Medicare services from Dr. Kline across 3 procedure codes in 2024, for 105 Medicare patients. Medicare paid $12,671 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 105 Medicare patients who saw Dr. Kline in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kline's median patient age at 42, with 58% women.

In 2024, Dr. Kline wrote 80 Medicare Part D claims for 62 patients. 96% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $141 in total drug cost. In 2023, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Kline for performance year 2024, reported as part of a group. Dr. Kline accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Kline from 3 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $157.

Dr. Kline graduated from Michigan State University College of Human Medicine in 2015.